Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88293837 | 8829383 | 7 | F | 201101 | 20160815 | 20121008 | 20160819 | EXP | BR-ROCHE-729322 | ROCHE | 52.05 | YR | F | Y | 84.00000 | KG | 20160819 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88293837 | 8829383 | 1 | PS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | DOSE: 500MG/50ML | U | U | 103705 | 1000 | MG | SOLUTION FOR INFUSION | |||||
| 88293837 | 8829383 | 2 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | U | 103705 | SOLUTION FOR INFUSION | ||||||||
| 88293837 | 8829383 | 3 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | U | 103705 | SOLUTION FOR INFUSION | ||||||||
| 88293837 | 8829383 | 4 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | U | 103705 | SOLUTION FOR INFUSION | ||||||||
| 88293837 | 8829383 | 5 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | U | 103705 | SOLUTION FOR INFUSION | ||||||||
| 88293837 | 8829383 | 6 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | U | 103705 | SOLUTION FOR INFUSION | ||||||||
| 88293837 | 8829383 | 7 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | U | 103705 | SOLUTION FOR INFUSION | ||||||||
| 88293837 | 8829383 | 8 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | U | 103705 | SOLUTION FOR INFUSION | ||||||||
| 88293837 | 8829383 | 9 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | U | 103705 | 1000 | MG | SOLUTION FOR INFUSION | ||||||
| 88293837 | 8829383 | 10 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | LAST INFUSION ON 23/NOV/2015 | U | U | 103705 | SOLUTION FOR INFUSION | |||||||
| 88293837 | 8829383 | 11 | SS | NICOTINIC ACID | NIACIN | 1 | Unknown | THERAPY SUSPENDED | 0 | ||||||||||
| 88293837 | 8829383 | 12 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Unknown | INDICATION: UNSPECIFIED TRIGLYCERIDE DISORDER | 0 | ||||||||||
| 88293837 | 8829383 | 13 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Unknown | 0 | 20 | MG | |||||||||
| 88293837 | 8829383 | 14 | C | NAPROXEN. | NAPROXEN | 1 | Unknown | 0 | 500 | MG | |||||||||
| 88293837 | 8829383 | 15 | C | MODURETIC 5-50 | AMILORIDE HYDROCHLORIDEHYDROCHLOROTHIAZIDE | 1 | Unknown | 0 | 5 | MG | |||||||||
| 88293837 | 8829383 | 16 | C | EUTHYROX | LEVOTHYROXINE SODIUM | 1 | Unknown | DAILY | 0 | 150 | MG | ||||||||
| 88293837 | 8829383 | 17 | C | EUTHYROX | LEVOTHYROXINE SODIUM | 1 | Unknown | 0 | 75 | MG | TABLET | QD | |||||||
| 88293837 | 8829383 | 18 | C | METICORTEN | PREDNISONE | 1 | Unknown | 0 | 5 | MG | |||||||||
| 88293837 | 8829383 | 19 | C | ARAVA | LEFLUNOMIDE | 1 | 0 | ||||||||||||
| 88293837 | 8829383 | 20 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Unknown | 0 | |||||||||||
| 88293837 | 8829383 | 21 | C | LOSARTAN. | LOSARTAN | 1 | Unknown | 0 | 5 | MG | |||||||||
| 88293837 | 8829383 | 22 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | DAILY | 0 | 2.5 | MG | ||||||||
| 88293837 | 8829383 | 23 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 0 | 2.5 | MG | |||||||||
| 88293837 | 8829383 | 24 | C | EZETROL | EZETIMIBE | 1 | Unknown | 0 | 10 | MG | |||||||||
| 88293837 | 8829383 | 25 | C | AAS | ASPIRIN | 1 | 0 | ||||||||||||
| 88293837 | 8829383 | 26 | C | ATROPINE. | ATROPINE | 1 | 0 | ||||||||||||
| 88293837 | 8829383 | 27 | C | GLIFAGE | METFORMIN HYDROCHLORIDE | 1 | Unknown | DAILY | 0 | ||||||||||
| 88293837 | 8829383 | 28 | C | FORASEQ (BRAZIL) | BUDESONIDEFORMOTEROL FUMARATE | 1 | Unknown | 400/12 MG | 0 | TABLET | BID | ||||||||
| 88293837 | 8829383 | 29 | C | GLIFAGE XR | METFORMIN HYDROCHLORIDE | 1 | Unknown | 0 | 500 | MG | TABLET | QD | |||||||
| 88293837 | 8829383 | 30 | C | ARADOIS | LOSARTAN POTASSIUM | 1 | Unknown | 0 | 50 | MG | TABLET | QD | |||||||
| 88293837 | 8829383 | 31 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Unknown | DAILY | 0 | ||||||||||
| 88293837 | 8829383 | 32 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | 0 | 20 | MG | TABLET | BID | |||||||
| 88293837 | 8829383 | 33 | C | TAMSULOSINA | TAMSULOSIN HYDROCHLORIDE | 1 | Unknown | DAILY | 0 | ||||||||||
| 88293837 | 8829383 | 34 | C | PREBICTAL | PREGABALIN | 1 | Unknown | 0 | 75 | MG | TABLET | QD | |||||||
| 88293837 | 8829383 | 35 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | 0 | 20 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 88293837 | 8829383 | 1 | Rheumatoid arthritis |
| 88293837 | 8829383 | 11 | Blood pressure measurement |
| 88293837 | 8829383 | 16 | Thyroid cancer |
| 88293837 | 8829383 | 20 | Premedication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 88293837 | 8829383 | HO |
| 88293837 | 8829383 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 88293837 | 8829383 | Application site reaction | |
| 88293837 | 8829383 | Arthralgia | |
| 88293837 | 8829383 | Asthenia | |
| 88293837 | 8829383 | Back pain | |
| 88293837 | 8829383 | Benign neoplasm | |
| 88293837 | 8829383 | Chest pain | |
| 88293837 | 8829383 | Diabetes mellitus | |
| 88293837 | 8829383 | Diarrhoea | |
| 88293837 | 8829383 | Dizziness | |
| 88293837 | 8829383 | Dyspnoea | |
| 88293837 | 8829383 | Ear disorder | |
| 88293837 | 8829383 | Fall | |
| 88293837 | 8829383 | Fatigue | |
| 88293837 | 8829383 | Gait disturbance | |
| 88293837 | 8829383 | Glucose tolerance impaired | |
| 88293837 | 8829383 | Influenza | |
| 88293837 | 8829383 | Limb discomfort | |
| 88293837 | 8829383 | Lung disorder | |
| 88293837 | 8829383 | Lymphoma | |
| 88293837 | 8829383 | Malaise | |
| 88293837 | 8829383 | Muscle spasms | |
| 88293837 | 8829383 | Muscular weakness | |
| 88293837 | 8829383 | Oesophageal disorder | |
| 88293837 | 8829383 | Pain | |
| 88293837 | 8829383 | Pain in extremity | |
| 88293837 | 8829383 | Sensory disturbance | |
| 88293837 | 8829383 | Spinal pain | |
| 88293837 | 8829383 | Urinary incontinence | |
| 88293837 | 8829383 | Vertigo | |
| 88293837 | 8829383 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 88293837 | 8829383 | 1 | 20080721 | 200908 | 0 | |
| 88293837 | 8829383 | 4 | 20100611 | 20100625 | 0 | |
| 88293837 | 8829383 | 5 | 20110328 | 20110411 | 0 | |
| 88293837 | 8829383 | 6 | 20120315 | 20120329 | 0 | |
| 88293837 | 8829383 | 8 | 20130507 | 20130521 | 0 | |
| 88293837 | 8829383 | 9 | 20100524 | 20100607 | 0 | |
| 88293837 | 8829383 | 10 | 20100501 | 20130522 | 0 | |
| 88293837 | 8829383 | 20 | 20080721 | 20100607 | 0 |